Patented biomarker for cardiac injury. 

cMyC (Cardiac Myosin-binding protein C)

A distinctive cardiac necrosis biomarker for early triaging chest pain patients. It rises faster to detectable levels compared to troponin in the event of an Acute Myocardial Infarction. This makes it suitable for PoC platforms.

Using cMyC reduces patients in observation groups in the Emergency Department => Cost saving for hospitals!

It is mentioned in the ESC guidelines for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation.

Latest publications

cMyC (Cardiac Myosin-binding protein C)

A distinctive cardiac necrosis biomarker for early triaging chest pain patients. It rises faster to detectable levels compared to troponin in the event of an Acute Myocardial Infarction. This makes it suitable for PoC platforms.

Using cMyC reduces patients in observation groups in the Emergency Department => Cost saving for hospitals!

It is mentioned in the ESC guidelines for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation.

Rotating Heart Illustration 148860803 © Sutthiphorn Phanchart | Dreamstime.com

A cardiac specific biomarker for Acute Myocardial Infarction.

Image of a cMyC Protein, a Cardiac specific biomarker to be used for triaging acute myocardial infarction (AMI).
A cardiac specific biomarker for Acute Myocardial Infarction.
Image of a cMyC Protein, a Cardiac specific biomarker to be used for triaging acute myocardial infarction (AMI).

Rotating Heart Illustration 148860803 © Sutthiphorn Phanchart | Dreamstime.com